Rajput Chatrasal Singh, Singhal Shiwani
Medicinal Chemistry Division, Department of Pharmacology, L.L.R.M. Medical College, Meerut 250002, India ; Jubilant Chemsys Ltd. R & D B-34, Sector 58, Noida 201301, India.
Medicinal Chemistry Division, Department of Pharmacology, L.L.R.M. Medical College, Meerut 250002, India.
J Pharm (Cairo). 2013;2013:907525. doi: 10.1155/2013/907525. Epub 2013 Jan 17.
A series of 3-[2'-(Substitutedbenzylideneamino)phenyl]-2-methyl-6-substituted quinazolin-4-ones (5-10), 3-[2'-(3(″)-chloro-2(″)-oxo-4(″)-substitutedphenylazetidin-1(″)-yl)phenyl]-2-methyl-6-substitutedquinazolin-4-ones (11-16), and 3-[2'-(2(″)-substitutedphenyl-4(″)-oxo-1(″),3(″)-thiazolidin-3(″)-yl)phentl]-2-methyl-6-substitutedquinazolin-4-ones (17-22) have been synthesized in the present study. The structures of the synthesized compounds were assigned on the basis of elemental analysis, IR, (1)H NMR, and mass spectral data. All the newly synthesized compounds were screened for anti-inflammatory and analgesic activities.
本研究合成了一系列3-[2'-(取代亚苄基氨基)苯基]-2-甲基-6-取代喹唑啉-4-酮(5-10)、3-[2'-(3(″)-氯-2(″)-氧代-4(″)-取代苯基氮杂环丁烷-1(″)-基)苯基]-2-甲基-6-取代喹唑啉-4-酮(11-16)和3-[2'-(2(″)-取代苯基-4(″)-氧代-1(″),3(″)-噻唑烷-3(″)-基)苯基]-2-甲基-6-取代喹唑啉-4-酮(17-22)。根据元素分析、红外光谱、(1)H核磁共振和质谱数据确定了合成化合物的结构。对所有新合成的化合物进行了抗炎和镇痛活性筛选。